Ann Tanabe, the current Chief Executive Officer of BioHouston, has over 15 years of experience working in numerous roles in the Biotechnology Industry. Ann was promoted to CEO of BioHouston in October 2015 after serving four years as VP of Investor Relations at Synthesis Energy Systems, a publicly traded energy company from May 2008 to December 2010. Preceding her success at both BioHouston and Sythesis Energy Systems, Ann served as VP of Corporate Communications & Investor Relations at Encysive Pharmaceuticals, previously known as Texas Biotechnology.